Show/hide contentOpenClose All
Curricular information is subject to change
Upon completion of the module, the student will be able to:
Describe properties / characteristics and rationalise the use of biomaterials, tissue grafts, cell-derived matrices and advanced therapy medicinal products in medical device, pharmaceutical, tissue engineering, regenerative medicine, cell culture technologies and cellular agriculture sectors.
Select appropriate biomaterial(s) and processing method(s) for the development of devices for a specific sector.
Specify biophysical, biochemical and biological in vitro microenvironment modulators that control cell fate.
Specify suitable methods for biophysical, biochemical and biological characterisation of devices for a specific sector.
Understand mechanisms involved in implant failure.
Understand cytocompatibility and biocompatibility.
Appreciate regulatory requirements in the development of implantable devices.
Appreciate ethical considerations in biomaterials field.
Appreciate financial management, innovation, commercialisation and clinical translation.
Report and disseminate scientific findings to diverse audiences.
Demonstrate knowledge and understanding of the mathematics, sciences, data science, analytics, etc. underpinning biomaterials / tissue engineering.
Demonstrate the ability to identify, formulate and analyse biomaterials-related problems.
Demonstrate the ability to work independently and as part of a group.
Demonstrate the ability to investigate, experiment and conduct hypothesis-driven research.
Definitions of biomaterials, biocompatibility, advanced therapy medicinal products.
Introduction to different classes of biomaterials.
Introduction to bottom-up or top-down and nano or micro biomaterial processing methods.
Introduction to biomaterials characterisation.
Discussion on implant failure.
Introduction to cellular systems and discussion on how we can control cell fate.
Introduction to commercialisation, clinical translation and regulatory requirements.
Discussion on ethical issues associated with biomaterials development.
Designing biomaterials and advanced therapy medicinal products for specific indications.
Designing clinical-indication specific experiments.
Data analysis and report writing.
Invited talks.
Student Effort Type | Hours |
---|---|
Lectures | 18 |
Seminar (or Webinar) | 4 |
Computer Aided Lab | 4 |
Specified Learning Activities | 5 |
Autonomous Student Learning | 100 |
Total | 131 |
Not applicable to this module.
Description | Timing | Component Scale | % of Final Grade | ||
---|---|---|---|---|---|
Participation in Learning Activities: Four short Individual reports (2.5 % each) related to invited talks. | n/a | Standard conversion grade scale 40% | No | 10 |
|
Group Work Assignment: A group-based laboratory report | n/a | Standard conversion grade scale 40% | No | 40 |
|
Exam (In-person): A closed-book in-class exam that will take place the last week of the semester. | n/a | Standard conversion grade scale 40% | No | 50 |
Remediation Type | Remediation Timing |
---|---|
In-Module Resit | Prior to relevant Programme Exam Board |
• Feedback individually to students, post-assessment
• Group/class feedback, post-assessment
• Online automated feedback
• Peer review activities
• Self-assessment activities
Letter grades and brief comments related to the two written assignments will be provided to students within three weeks of submission deadlines.